Seeking Alpha

Amylin (AMLN) has apparently attracted interest from potential suitors including Pfizer (PFE),...

Amylin (AMLN) has apparently attracted interest from potential suitors including Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers (BMY) and Sanofi (SNY), all of which have signed confidentiality agreements on the drugmaker's sale process. Sources say first-round bids are due in the next two weeks.
Comments (2)
  • norjud
    , contributor
    Comments (225) | Send Message
     
    Let the bidding begin...I have PFE has the edge...
    15 May 2012, 08:37 AM Reply Like
  • ralphey
    , contributor
    Comments (346) | Send Message
     
    $38 --- ICahn was so wrong at $22 could have cost shareholders a FORTUNE !!!
    15 May 2012, 09:54 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector